Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05920161 · ClinicalTrials.gov registry record · NA

Influence of Stress on Encoding and Prediction

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT05920161: Completed NA study, sponsored by Yale University.

NCT05920161 is a NA study that has completed, run by Yale University. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05920161, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the neural mechanisms by which acute stress influences statistical learning and episodic encoding.

Primary Outcome

fMRI signal during learning will be assessed using connectivity, multivariate, and univariate approaches over 1-2 hour long learning period. Correlation between change in CA1-EC background connectivity and pair familiarity. rho represents the true correlation within the entire population, with values ranging from -1 to +1; values closer to +1 indicate a strong positive linear relationship, closer to -1 a strong negative one, and closer to 0 indicate no linear relationship.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Socially Evaluated Cold Pressor Test

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2023-03-02
Est. Completion 2024-10-04
Phase NA
Yale University

1,492 total trials

What the finished NCT05920161 record still lists

NCT05920161 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT05920161 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05920161 about?

NCT05920161 is a clinical study titled "Influence of Stress on Encoding and Prediction". The purpose of this study is to investigate the neural mechanisms by which acute stress influences statistical learning and episodic encoding.

What is the current status of trial NCT05920161?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2023-03-02. Estimated completion is 2024-10-04.

What interventions are being tested in trial NCT05920161?

The interventions under investigation include: Control (BEHAVIORAL), Socially Evaluated Cold Pressor Test (BEHAVIORAL).

Who is sponsoring clinical trial NCT05920161?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05920161's enrollment target sits among peer trials

106 830th of 2000 higher than 1,167 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05920161, the US trial registry maintained by the National Library of Medicine. NCT05920161 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.